News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
283,324 Results
Type
Article (15078)
Company Profile (299)
Press Release (267941)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80249)
Career Advice (179)
Deals (13394)
Drug Delivery (39)
Drug Development (50917)
Employer Resources (34)
FDA (5870)
Job Trends (5202)
News (145793)
Policy (10185)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (936)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21848)
ALS (125)
Alzheimer's disease (1034)
Antibody-drug conjugate (ADC) (241)
Approvals (6064)
Artificial intelligence (260)
Autoimmune disease (112)
Automation (9)
Bankruptcy (106)
Best Places to Work (4590)
BIOSECURE Act (7)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3132)
Cardiovascular disease (238)
Career advice (161)
Career pathing (8)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43795)
Collaboration (1149)
Company closure (2)
Compensation (596)
Complete response letters (39)
COVID-19 (1160)
CRISPR (86)
C-suite (551)
Cystic fibrosis (112)
Data (4326)
Denatured (15)
Depression (92)
Diabetes (256)
Diagnostics (1390)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (189)
Drug pricing (50)
Drug shortages (3)
Duchenne muscular dystrophy (215)
Earnings (31796)
Editorial (28)
Employer branding (4)
Employer resources (32)
Events (51953)
Executive appointments (623)
FDA (7625)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (985)
Gene editing (182)
Generative AI (21)
Gene therapy (487)
GLP-1 (508)
Government (1182)
Grass and pollen (3)
Guidances (167)
Healthcare (6711)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1265)
Inflammatory bowel disease (156)
Inflation Reduction Act (11)
Influenza (38)
Intellectual property (167)
Interviews (20)
IPO (7387)
IRA (12)
Job creations (872)
Job search strategy (141)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (11)
Legal (1421)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (249)
Machine learning (24)
Management (9)
Manufacturing (377)
MASH (130)
Medical device (2716)
Medtech (2725)
Mergers & acquisitions (6629)
Metabolic disorders (727)
Multiple sclerosis (104)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1957)
Neurotech (1)
NextGen: Class of 2026 (2074)
Non-profit (909)
Now hiring (30)
Obesity (331)
Opinion (132)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (233)
Partnered (12)
Patents (304)
Patient recruitment (329)
Peanut (43)
People (26773)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15510)
Phase 2 (20357)
Phase 3 (12873)
Pipeline (3257)
Policy (94)
Postmarket research (853)
Preclinical (6552)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (649)
Real estate (1469)
Recruiting (14)
Regulatory (9964)
Reports (19)
Research institute (978)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (123)
Series A (182)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2010)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (19)
The Weekly (62)
Vaccines (338)
Venture capital (69)
Weight loss (176)
Women's health (25)
Worklife (2)
Date
Today (25)
Last 7 days (340)
Last 30 days (1140)
Last 365 days (17848)
2026 (1677)
2025 (18126)
2024 (20598)
2023 (22490)
2022 (26936)
2021 (28030)
2020 (23713)
2019 (16376)
2018 (11891)
2017 (13837)
2016 (11921)
2015 (14412)
2014 (10455)
2013 (7522)
2012 (7565)
2011 (7644)
2010 (7456)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (71)
Arkansas (6)
Asia (18323)
Australia (3144)
California (7082)
Canada (1837)
China (774)
Colorado (255)
Connecticut (252)
Delaware (235)
Europe (39303)
Florida (908)
Georgia (209)
Hawaii (2)
Idaho (17)
Illinois (399)
India (35)
Indiana (160)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (740)
Massachusetts (5586)
Michigan (111)
Minnesota (248)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1653)
New Mexico (13)
New York (1763)
North Carolina (829)
North Dakota (6)
Northern California (3476)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1280)
Puerto Rico (9)
Rhode Island (25)
South America (224)
South Carolina (9)
Southern California (2809)
Tennessee (40)
Texas (906)
United States (23381)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (592)
West Virginia (1)
Wisconsin (45)
283,324 Results for "storm therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Latest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
November 3, 2025
·
8 min read
Press Releases
Qaelon Medical Announces Formation of Scientific Advisory Board and Appoints Dr. Andrew Storm
August 20, 2025
·
3 min read
Press Releases
Landmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
October 28, 2025
·
7 min read
Press Releases
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
May 27, 2025
·
6 min read
Press Releases
Penumbra, Inc. Announces Completion of Enrollment for Landmark STORM-PE Randomized Controlled Trial
June 16, 2025
·
5 min read
FDA
FDA After the Storm: Drug Review Delays and Increased Executive Oversight Expected
After the gutting of the Department of Health and Human Services, fears mount about the future direction of the FDA—with regulatory experts predicting delays in drug approvals and greater influence of political appointees.
April 14, 2025
·
6 min read
·
Heather McKenzie
Editorial
FDA Weathers Bait-and-Switch Storm as Staff and Sites Come and Go
Marty Makary, likely FDA commissioner under President Trump, appeared before Congress this week as the agency he’s set to lead continues to be rocked by sweeping changes and about-faces.
March 7, 2025
·
3 min read
·
Jef Akst
Opinion
How Biotechs Can Navigate NIH Cuts
A ripple effect of the NIH’s slashed 2026 budget will be felt throughout the biopharma ecosystem. Young companies must act now to weather the storm.
August 4, 2025
·
5 min read
·
Justin Kozak
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Biotech Beach
First Patient in STORM-PE RCT Enrolled Evaluating Penumbra’s Latest Computer Assisted Vacuum Thrombectomy - Lightning Flash™ - for Treatment of Acute Pulmonary Embolism
Penumbra, Inc. announced the first patient enrolled in STORM-PE, a first-of-its-kind prospective, multi-center, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus Lightning Flash™ for the treatment of pulmonary embolism (PE).
November 28, 2023
·
6 min read
1 of 28,333
Next
